Pfizer Inc on Tuesday reported lower-than-expected quarterly profit and a declin...
FILE PHOTO: The Pfizer logo is seen at their world headquarters in Manhattan, New York, U.S., August 1, 2016. REUTERS/Andrew Kelly
The largest U.S. drugmaker is spinning off its struggling Upjohn unit, which houses off-patent drugs including Lyrica and Viagra, and separated its consumer health business last year to focus on its more profitable drugs. Sales of breast cancer drug Ibrance, a growth driver for Pfizer, rose 13% to $1.28 billion in the quarter, but missed the consensus estimate of $1.35 billion, according to IBES data from Refinitiv.Excluding one-time items, Pfizer earned 55 cents per share, below the average analyst estimate of 58 cents. Operating costs rose 1%.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Lockheed Martin beats estimates, raises sales forecast on higher F-35 deliveriesLockheed Martin Corp forecast 2020 revenue above analysts' estimates on Tue...
Consulte Mais informação »
Xerox's quarterly profit beats estimates, says firm on HP buyoutXerox Holdings Corp on Tuesday posted a better-than-expected quarterly profit as...
Consulte Mais informação »
Coronavirus infects Asia stocks with exposure to ChinaShares of companies highly exposed to China's economy tumbled across Asia o...
Consulte Mais informação »
Kuwait could need $180 billion in financing over the next six years: IMFThe International Monetary Fund estimates that Kuwait's financing needs wil...
Consulte Mais informação »
TV Ratings: Grammys Fall a Little, Reach 12-Year Low in ViewersThe GRAMMYs ruled Sunday's ratings — although they were down a little year to year
Consulte Mais informação »